j code for semaglutide injection Weight loss drugs may become harder to get. What does that mean patients? GLP-1 - For Weight Loss

In China, the diabetes indication for the original drug semaglutide was included in the national medical insurance in 2021, but its weight-loss indication has not been covered by insurance to date, focusing mainly on the out-of-hospital self-pay market

Potential Mechanisms Underlying Weight Reduction and Metabolic Efficiency 7.2.1

In individuals with obesity, the skin may have been stretched out for years to accommodate larger fat volumes, which can result in a loss of elasticity and slower spring back after significant weight loss

Wegovy primarily works by suppressing appetite

This medication activates both GLP-1 and GIP receptors, which among other effects suppresses appetite and significantly slows the rate at which your stomach empties its contents into the small intestine

the two medications work best together to address both weight and lipid profiles